for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Nektar Therapeutics reports Q3 earnings per share $0.39

Nov 7 (Reuters) - Nektar Therapeutics:

* Nektar Therapeutics reports financial results for the third quarter of 2017

* Q3 earnings per share $0.39

* Q3 revenue $152.9 million versus $36.3 million

* Q3 revenue view $114.6 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up